Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Breast Implant Update: Scrutiny Continues

Executive Summary

At an FDA General and Plastic Surgery Devices panel held in August to make recommendations on postmarketing issues related to silicone gel breast implants, the agency said it will continue to monitor patient safety via the postapproval studies and surgeon adverse reports and has asked that groups work together to improve follow-up and registry enrollment.
Advertisement

Related Content

The Future of the Stem Cell Market
The Future of the Stem Cell Market

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT035454

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel